Previous Close | 1.1900 |
Open | 1.1100 |
Bid | 0.9894 x 200 |
Ask | 0.9954 x 200 |
Day's Range | 0.9800 - 1.1250 |
52 Week Range | 0.7100 - 1.9600 |
Volume | |
Avg. Volume | 1,504,816 |
Market Cap | 174.054M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2024. At this time, […]
Explore key financial outcomes and strategic directions from Rigel Pharmaceuticals' first quarter earnings call of 2024.
Rigel (RIGL) delivered earnings and revenue surprises of -66.67% and 5.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?